Progress on better access to medicines for patients in Europe

Significant progress was made in the work of the Process on Corporate Responsibility in the field of Pharmaceuticals with the endorsement of the outcomes of the Platform on Access to Medicines in Europe, at the meeting of the European Commission Steering Group on Access to Medicines in Ireland on April 17.

The deliverables for a better access to medicines in Europe under the Process on corporate responsibility in the field of pharmaceuticals have been finalized and are now available to the public. Under the Platform on Access to Medicines in Europe, experts representing pricing and reimbursement authorities, industry (research based innovators generics and non-prescription medicines producers and academia) were invited to work towards consensus based results, in five different project groups.

Market access for biosimilars